Further studies demonstrated that S100A11 is overexpressed in metastatic hepatoma cells, and S100A11 knockdown decreases hepatoma cells proliferation, migration, invasion and EMT progress by inhibiting AKT and ERK signaling pathways. This evidence concerns the gene AKT1 and hepatocellular carcinoma.